Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05743790 · ClinicalTrials.gov registry record · NA
The Role of Dietary Intake and Host Genetics in Gut Microbiome Response to Resistant Starch Consumption
A NA study, sponsored by Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 196
- Enrollment target
NCT05743790 is a NA study that has completed, run by Cornell University. The registered enrollment target is 196 participants.
The verdict
NCT05743790, a NA study, has completed, sponsored by Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 196 participants
- Enrollment target
Study Summary
Resistant starch (RS), a type of dietary fiber, was shown to have beneficial effects on human health through its impact on microbes present in the intestine. However, the effects of RS on the gut microbiota and in turn, on human health, can vary between individuals. Consequently, everyone may not reap the same health benefits by eating high amounts of RS. Factors predicting how an individual's gut microbes as well as the beneficial metabolites produced by these microbes respond to RS supplementation would be helpful in developing precision nutrition approaches that maximize the benefits of dietary fiber intake. The objective of this study was to evaluate candidate predictors of gut microbiota response to RS supplementation.
Interventions
- DIETARY_SUPPLEMENT RS2-control-RS4
- DIETARY_SUPPLEMENT RS4-control-RS2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2019-09-26 |
| Est. Completion | 2020-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05743790
The ClinicalTrials.gov registry entry for NCT05743790 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cornell University, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which RS2-control-RS4 is the first listed.
NCT05743790 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05743790 about?
NCT05743790 is a clinical study titled "The Role of Dietary Intake and Host Genetics in Gut Microbiome Response to Resistant Starch Consumption". Resistant starch (RS), a type of dietary fiber, was shown to have beneficial effects on human health through its impact on microbes present in the intestine. However, the effects of RS on the gut microbiota and in turn, on human health, can vary between individuals. Consequently, everyone may not re...
What is the current status of trial NCT05743790?
This trial is currently completed. It is a NA study. The enrollment target is 196 participants. The study started on 2019-09-26. Estimated completion is 2020-12-15.
What interventions are being tested in trial NCT05743790?
The interventions under investigation include: RS2-control-RS4 (DIETARY_SUPPLEMENT), RS4-control-RS2 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05743790?
This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.